Figure 2
From: Enhanced sensitivity to cisplatin and gemcitabine in Brca1-deficient murine mammary epithelial cells
Effect of Brca1 -deficiency on Sensitivity to Non-DNA Damaging Agents. Brca1+/+ (black circle) and Brca1-/- (white square) cells were analyzed for cellular sensitivity to taxanes, paclitaxel (a) or docetaxel (b), and to antimetabolites, 5-FU (c) or gemcitabine (d) by MTT assay. Each data point represents the average of triplicate readings ± S.D. Graphs are representative of at least three independent experiments.